2,194
Views
37
CrossRef citations to date
0
Altmetric
Pages 265-279 | Received 04 Jul 2011, Accepted 15 Sep 2011, Published online: 07 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Fatemeh Mokhtari, Bahareh Bahrami, Gita Faghihi, Ali Asilian & Fariba Iraji. (2022) Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. Journal of Dermatological Treatment 33:5, pages 2475-2481.
Read now
Nasrin Saki, Mohammad Darayesh & Alireza Heiran. (2018) Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. Journal of Dermatological Treatment 29:4, pages 405-410.
Read now
Caradee Y Wright, Lester M Davids, Beverley Summers & Mary Norval. (2013) Solar ultraviolet radiation in South Africa: clinical consequences for the skin. Expert Review of Dermatology 8:6, pages 693-706.
Read now
Marjorie F Yang & Lisa Y Xu. (2012) Laser and light-based treatments of hidradenitis suppurativa. Expert Review of Dermatology 7:2, pages 149-158.
Read now

Articles from other publishers (33)

Shilpi Goenka & Lorne M. Golub. (2023) In Vitro Study of the Effects of Five Chemically Modified Tetracycline (CMT) Analogs on Human Epidermal Melanogenesis: Potential as Novel Anti-Melanogenic Agents. Drugs and Drug Candidates 2:4, pages 810-826.
Crossref
Fatimata Ly. 2023. Pigmentation Disorders - Etiology and Recent Advances in Treatments. Pigmentation Disorders - Etiology and Recent Advances in Treatments.
Behrooz Kasraee. 2023. Pigmentation Disorders - Etiology and Recent Advances in Treatments. Pigmentation Disorders - Etiology and Recent Advances in Treatments.
Angel D. Pagan, Krystal Mitchell, Jenna Yousif & Michelle Henry. (2022) Diagnostic tools for hyperpigmentation disorders in skin of color: An updated review. Dermatological Reviews 4:1, pages 17-29.
Crossref
Kani Javedan, Fatemeh Hydarpur, Pardis Mohammadi Pour, Fariba Najafi, Shahla Mirzaeei, Roja Rahimi, Mohammad Mehdi Gravandi & Mohammad Hosein Farzaei. (2022) The formulation and efficacy of topical Dorema ammoniacum in treating Melasma: a randomized double-blind, placebo-controlled trial . Journal of Complementary and Integrative Medicine 19:3, pages 743-751.
Crossref
Zuzanna Piętowska, Danuta Nowicka & Jacek C. Szepietowski. (2022) Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review. International Journal of Environmental Research and Public Health 19:19, pages 12084.
Crossref
Afsaneh Sadeghzadeh‐Bazargan, Elham Behrangi, Niloufar Najar Nobari, Mohammadreza Ghassemi, Masoumeh Roohaninasab & Azadeh Goodarzi. (2022) Systematic review of clinical studies assessing the needling for treatment of melasma: Focusing on efficacy, safety, and recurrence rate. Journal of Cosmetic Dermatology 21:5, pages 1857-1873.
Crossref
Hülya TEZEL, Aylin BALCI & Pınar ERKEKOĞLU. (2022) Melazma Tedavisinde Güncel Yaklaşımlar Ve Olası Toksik Etkileri. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Najmeh Ahramiyanpour, Nasrin Saki, Zahra Akbari, Simin Shamsi‐Meymandi, Rezvan Amiri & Alireza Heiran. (2021) Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. Journal of Cosmetic Dermatology 20:11, pages 3593-3602.
Crossref
Maryam Karrabi, Jennifer David & Mohammad Sahebkar. (2020) Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman’s formula in subjects with epidermal melasma: A randomized, double‐blind clinical trial study. Skin Research and Technology 27:1, pages 24-31.
Crossref
Shymaa Hatem, Nada M. El Hoffy, Reham S. Elezaby, Maha Nasr, Amany O. Kamel & Seham A. Elkheshen. (2020) Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches. Journal of Drug Delivery Science and Technology 60, pages 101984.
Crossref
Nahla Shihab, Joedo Prihartono, Andrea Tovar‐Garza, Triana Agustin, Lili Legiawati & Amit G Pandya. (2020) Randomised, controlled, double‐blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. Australasian Journal of Dermatology 61:3, pages 237-242.
Crossref
Punyaphat Sirithanabadeekul, Arada Dannarongchai & Atchima Suwanchinda. (2019) Platelet‐rich plasma treatment for melasma: A pilot study. Journal of Cosmetic Dermatology 19:6, pages 1321-1327.
Crossref
Huijuan Zhao, Mengna Li, Xiaofeng Zhang, Li Li, Yan Yan & Baoxi Wang. (2019) Comparing the efficacy of Myjet‐assisted tranexamic acid and vitamin C in treating melasma: A split‐face controlled trial. Journal of Cosmetic Dermatology 19:1, pages 47-54.
Crossref
Behrooz Kasraee, Parvin Mansouri & Susan Farshi. (2018) Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula. Journal of Cosmetic Dermatology 18:1, pages 293-295.
Crossref
K. K. Asanka Sanjeewa, Young-jin Park, I. P. Shanura Fernando, Yong-Seok Ann, Chang-Ik Ko, Lei Wang, You-Jin Jeon & WonWoo Lee. (2018) Soft corals collected from Jeju Island inhibits the α-MSH-induced melanogenesis in B16F10 cells through activation of ERK. Fisheries and Aquatic Sciences 21:1.
Crossref
Mohammad Adil, SyedSuhail Amin & Mohd Mohtashim. (2018) N-acetylcysteine in dermatology. Indian Journal of Dermatology, Venereology and Leprology 84:6, pages 652.
Crossref
Juan Zhou, Tong Ren, Ying Li, Anran Cheng, Wanyi Xie, Lanxi Xu, Lu Peng, Jinbin Lin, Lianxiang Lian, Yong Diao, Xin Jin & Lichao Yang. (2017) Oleoylethanolamide inhibits α-melanocyte stimulating hormone-stimulated melanogenesis via ERK, Akt and CREB signaling pathways in B16 melanoma cells. Oncotarget 8:34, pages 56868-56879.
Crossref
Vahideh Lajevardi, Afsaneh Ghayoumi, Robabeh Abedini, Hamed Hosseini, Azadeh Goodarzi, Zahra Akbari & Kosar Hedayat. (2017) Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a shor. Journal of Cosmetic Dermatology 16:2, pages 235-242.
Crossref
Philip R. Cohen. (2017) Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor. Medical Hypotheses 101, pages 1-5.
Crossref
M.K. Trivedi, F.C. Yang & B.K. Cho. (2017) A review of laser and light therapy in melasma. International Journal of Women's Dermatology 3:1, pages 11-20.
Crossref
Mauricio Mota De Avelar Alchorne & Marilda Aparecida Milanez Morgado De Abreu. 2017. Tropical Dermatology. Tropical Dermatology 433 442 .
Ma. Flordeliz Abad-Casintahan & Hester Gail Lim. 2017. Melasma and Vitiligo in Brown Skin. Melasma and Vitiligo in Brown Skin 93 101 .
Hye Kyong Park, Nam Soo Kim, Tae Kee Moon, Bora Kim & Ho Young Jung. (2015) A Comparison Study Between Image Analysis and Conventional Methods in the Evaluation of Asian Skin Color. Journal of the Society of Cosmetic Scientists of Korea 41:2, pages 97-103.
Crossref
J. Kirschke, S. Hessam & F.G. Bechara. (2015) Hidradenitis suppurativa/Acne inversaHidradenitis suppurativa/acne inversa. Der Hautarzt 66:6, pages 413-422.
Crossref
SHAO-MIN ZHONG, NAN SUN, HUI-XIAN LIU, YUE-QING NIU & YAN WU. (2015) Reduction of facial pigmentation of melasma by topical lignin peroxidase: A novel fast-acting skin-lightening agent. Experimental and Therapeutic Medicine 9:2, pages 341-344.
Crossref
Ilaria Ghersetich, Lara Tripo, Alice Garzitto & Torello M. Lotti. 2015. European Handbook of Dermatological Treatments. European Handbook of Dermatological Treatments 1115 1127 .
Krupa Shankar, Kiran Godse, Sanjeev Aurangabadkar, Koushik Lahiri, Venkat Mysore, Anil Ganjoo, Maya Vedamurty, Malavika Kohli, Jaishree Sharad, Ganesh Kadhe, Pashmina Ahirrao, Varsha Narayanan & Salman Abdulrehman Motlekar. (2014) Evidence-Based Treatment for Melasma: Expert Opinion and a Review. Dermatology and Therapy 4:2, pages 165-186.
Crossref
Horng-Huey Ko, Yao-Chang Chiang, Ming-Horng Tsai, Chan-Jung Liang, Lee-Fen Hsu, Shu-Yu Li, Moo-Chin Wang, Feng-Lin Yen & Chiang-Wen Lee. (2014) Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways. Journal of Ethnopharmacology 151:1, pages 386-393.
Crossref
Said Hilton, Heike Heise, Bettina Alexandra Buhren, Holger Schrumpf, Edwin Bölke & Peter Arne Gerber. (2013) Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser. European Journal of Medical Research 18:1.
Crossref
Jung U Shin, Jihun Park, Sang Ho Oh & Ju Hee Lee. (2013) Oral Tranexamic Acid Enhances the Efficacy of Low-Fluence 1064-Nm Quality-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial. Dermatologic Surgery 39:3, pages 435-442.
Crossref
Cheng Yao, Jang-hee Oh, Inn Gyung Oh, Chi-hyun Park & Jin Ho Chung. (2012) [6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacologica Sinica 34:2, pages 289-294.
Crossref
Feng-Lin Yen, Moo-Chin Wang, Chan-Jung Liang, Horng-Huey Ko & Chiang-Wen Lee. (2012) Melanogenesis Inhibitor(s) from Phyla nodiflora Extract . Evidence-Based Complementary and Alternative Medicine 2012, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.